1-4 of 4
Riitta Lassila, MD PhD
Close
Sort by
Journal Articles

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

Manuel Carcao, Carmen Altisent, PhD, Giancarlo Castaman, Katsuyuki Fukutake, MD PhD, Aida Inbal, MD, Bryce A. Kerlin, Craig M. Kessler, MD, Riitta Lassila, MD PhD, Johannes Oldenburg, Prof, Anders Rosholm, May-Lill Garly, MD PhD, Diane J. Nugent, MD
Journal: Blood
Blood (2016) 128 (22): 2573.
https://doi.org/10.1182/blood.V128.22.2573.2573
Published: 2016
Journal Articles

A Locally Administered Novel Heparin Complex Attenuates Collagen-Induced Platelet Activation and Thrombosis In Vivo ,

Riitta Lassila, MD, PhD, Associate Professor, Annukka Jouppila, M.Sci, Ulla M Marzec, MS, Stephen R Hanson, PhD, Prof.
Journal: Blood
Blood (2011) 118 (21): 3361.
https://doi.org/10.1182/blood.V118.21.3361.3361
Published: 2011
Journal Articles

Management Strategies of Stroke and Acute Coronary Syndrome In Von Willebrand Disease and Hemophilia: Experience From a Case Series and a Swiss Survey of Frequencies.

Sara C. Meyer, MD, PhD, Elina Armstrong, MD, PhD, Christine Perdrizat, Hans-Rudolf Schmid, PhD, Riitta Lassila, MD, PhD, Juerg H. Beer, MD
Journal: Blood
Blood (2010) 116 (21): 1406.
https://doi.org/10.1182/blood.V116.21.1406.1406
Published: 2010
Journal Articles

Adaptation of Coagulation and Fibrinolysis in Allogeneic Stem Cell Transplantation.

Anne Pinomaki, MD, Liisa Volin, MD, PhD, Lotta Joutsi-Korhonen, MD,PhD, Jussi Oskari Virtanen, MSc, Marja Lemponen labtech, Tapani Ruutu, MD,PhD, Riitta Lassila, MD,PhD
Journal: Blood
Blood (2007) 110 (11): 3023.
https://doi.org/10.1182/blood.V110.11.3023.3023
Published: 2007